Información sobre riesgo, prevención, detección, síntomas, diagnosis, tratamiento y apoyo para el cáncer.
Información sobre el tratamiento del cáncer incluyendo quirúrgica, quimioterapia, radioterapia, estudios clínicos, terapia con protón, medicina complementaria avanzadas.
OncoLink se complace en ofrecer una amplia lista de lista completa de los agentes quimioterapéuticos más comúnmente usados??. Esta guía de referencia incluye información sobre la forma en que cada fármaco se administra, cómo funcionan, y los pacientes los efectos secundarios comunes pueden experimentar.
Maneras que los pacientes de cáncer y las personas que le cuidan puedan enfrentar el cáncer, los efectos secundarios, nutrición, cuestiones en general sobre el apoyo para el cáncer, duelo/decisiones sobre el termino de vida, y experiencias compartidas por sobrevivientes.
Tipos de Cancer / Mielomas / Recursos de NCI
|
NCI CANCERLIT® Search: Plasma Cell Neoplasm - October 2001
IgA myeloma associated with decreased anion gap and renal failure. Normal frequencies of the C677T genotypes on the methylenetetrahydrofolate reductase (MTHFR) gene among [Osmotic activity of plasma in plasmapheresis in patients with multiple ... |
|
|
NCI CANCERLIT® Search: Plasma Cell Neoplasm - September 2001
Table of ContentsApoptosis in multiple myeloma: therapeutic implications.Analysis of clonal relationship using single-cell polymerase chain reaction in a patient with concomitant mantle cell lymphoma and multiple myeloma.[Laryngeal... |
|
|
NCI CANCERLIT® Search: Plasma Cell Neoplasm - April 2002
Autocrine production and synergistic growth-promoting activity of interleukin-6 and oncostatin M in a new human myeloma cell line TU-1. Hepatic failure due to CD3+ plasma cell infiltration of the liver in multiple myeloma. Hypothyroidism... |
|
|
NCI CANCERLIT® Search: Plasma Cell Neoplasm - August 2002
Clinical images: osteosclerotic myeloma associated with the POEMS syndrome. Myeloma and monoclonal gammopathy of uncertain significance associated with acquired von Willebrand's syndrome. Seven new cases with a Thalidomide in the... |
|
|
NCI CANCERLIT® Search: Plasma Cell Neoplasm - February 2002
Deep venous thrombosis and thalidomide therapy for multiple myeloma. The revitalization of thalidomide. Thalidomide and dexamethasone combination for refractory multiple myeloma. Association and contribution of ERK to IL-6-induced activation of... |
|
|
NCI CANCERLIT® Search: Plasma Cell Neoplasm - January 2002
High-dose melphalan with G-CSF-stimulated whole blood rescue followed by stem cell harvesting and busulphan/cyclophosphamide with autologous stem Thalidomide: near complete regression of extramedullary bulk in refractory multiple myeloma.... |
|
|
NCI CANCERLIT® Search: Plasma Cell Neoplasm - July 2002
Bone marrow transplantation for multiple myeloma: where we are today. Optimizing dendritic cell-based immunotherapy in multiple myeloma. Interleukin 6 and tumour necrosis factor alpha serum levels in monoclonal gammopathy of undetermined... |
|
|
NCI CANCERLIT® Search: Plasma Cell Neoplasm - June 2002
[New trends in the therapy of myeloma] Randomized, double-blind, placebo-controlled trial of recombinant human erythropoietin, epoetin Beta, in hematologic malignancies. IgM myeloma: a report of four cases. Multiple myeloma following an... |
|
|
NCI CANCERLIT® Search: Plasma Cell Neoplasm - March 2002
Cyclosporin A combined with vincristine, doxorubicin and dexamethasone (VAD) compared with VAD alone in patients with advanced refractory Comparison of 200 mg/m(2) melphalan and 8 Gy total body irradiation plus 140 mg/m(2) melphalan as... |
|
|
NCI CANCERLIT® Search: Plasma Cell Neoplasm - May 2002
The role of high-dose chemotherapy and stem-cell transplantation in patients with multiple myeloma: a practice guideline of the Cancer Care Unilateral sixth cranial nerve palsy caused by skull base mass lesions: case series. Are myeloma... |
|
|
NCI CANCERLIT® Search: Plasma Cell Neoplasm - October 2002
Changes in T cell receptor repertoire associated with graft-versus-tumor effect and graft-versus-host disease in patients with relapsed multiple [Signal transduction and biological function of IL-6 in a human myeloma cell line-XG-7] ... |
|
|
NCI CANCERLIT® Search: Plasma Cell Neoplasm - September 2002
Tender preauricular swelling. IgA myeloma presenting as diabetes mellitus with refractory anaemia. [Breast plasmacytoma. A new case] [Plasma cell leukemia: aggressive form of multiple myeloma] Second response to lower-dose thalidomide in a... |
|
|
NCI/PDQ® Health professionals: Plasma Cell Neoplasms (Including Multiple Myeloma) Treatment (PDQ®)
TABLE OF CONTENTS General Information About Plasma Cell Neoplasms Incidence and MortalityClinical Presentation and EvaluationEvaluation of patients with monoclonal (or myeloma) protein (M protein)Monoclonal Gammopathy of Undetermined Significance... |
|
|
NCI/PDQ® Pacientes:
TABLE OF CONTENTS Descripción¿Qué es la neoplasia de células plasmáticas?Explicación de los estadiosEstadios de la neoplasia de células plasmáticasMieloma móltipleMieloma móltiple en estadio IMieloma... |
|
|
NCI/PDQ® Patients: Multiple Myeloma and Other Plasma Cell Neoplasms
TABLE OF CONTENTS DescriptionWhat are plasma cell neoplasms?Stage ExplanationStages of plasma cell neoplasmsMultiple myelomaStage I multiple myelomaStage II multiple myelomaStage III multiple myelomaIsolated plasmacytoma of boneExtramedullary... |
|
|
NCI/PDQ® Profesionales De Salud: Neoplasias de células plasmáticas (incluso mieloma móltiple): Tratamiento (PDQ®)
TABLE OF CONTENTS Información general sobre las neoplasias de células plasmáticasIncidencia y mortalidadPresentación clínica y evaluaciónEvaluación de pacientes con proteína (proteína M) monoclonal (o... |
Dr. Vapiwala discusses the decisions to screen for breast and prostate cancers. Read more.
Cancer Types
Bone Cancer
Brain Tumors
Breast Cancer
Carcinoid Tumors
Endocrine System Cancers
Gastrointestinal Cancers
Gynecologic Cancers
Head and Neck Cancers
Leukemia
Lung Cancers
Lymphomas
Myelomas
Pediatric Cancers
Penile Cancer
Prostate Cancer
Sarcomas
Skin Cancers
Testicular Cancer
Thyroid Cancer
Urinary Tract Cancers
OncoLink Vet
Cancer Treatment
Biologic Therapy
Bone Marrow Transplants
Chemotherapy
Clinical Trials
Complementary Medicine
Gene Therapy
General Treatment Concerns
Hormone Therapy
PDT Center
Proton Therapy
Radiation Oncology
Surgical Oncology
Targeted Therapies
Vaccine Therapies
Cancer Support
Caregivers
Hospice Care and Bereavement
Nutrition and Cancer
Sexuality & Fertility
Side Effects
Support
Survivorship
Exercise and Cancer
Cancer Resources
Cancer News
OncoLink University
Nurses' Notes
Conferences
Newly Diagnosed Patients
Causes and Prevention
Legal and Financial Information for Patients
LGBT Resources
NCI Resources
Global Resources
Cancer Resource List
Resources for Young Adults
OncoLink Media Library
OncoLink TV
Book, Music and Video Reviews
Ask the Experts
Brown Bag Chat
Tracy's Corner
About OncoLink
About OncoLink
Giving to OncoLink
Contact Information
Usage Policy
Editorial Board
How to Partner with OncoLink
Link to OncoLink
Mission Statement
Calcium Leucovorin, Citrovorum Factor, Folinic Acid
Cladribine (2-CDA, Leustatin®)
Cyclophosphamide (Cytoxan®, Neosar®, Endoxan®)
Cyclosporine (Neoral®, Sandimmune®, Restasis®, Gengraf®)
Cytarabine (Cytosar-U®, Ara-C)
Irinotecan (Camptosar®, CPT-11)
Leucovorin (Calcium Leucovorin, Citrovorum Factor, Folinic Acid)
Calcium Leucovorin, Citrovorum Factor, Folinic Acid
Leucovorin (Calcium Leucovorin, Citrovorum Factor, Folinic Acid)
Leuprolide Acetate (Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®) - For Men
Leuprolide Acetate (Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®) - For Women
Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®
Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®
Busulfan (Myleran®, Busulfex®)
Intravesicular Mitomycin (Mutamycin®, Mitomycin-C, given into the bladder)
Mechlorethamine (Mustargen®, Nitrogen Mustard)
mechlorethamine, mustine, Mustargen®
Megestrol (Megace®, Megace-ES®)
Mercaptopurine (Purinethol®, 6-MP)
Methotrexate (Mexate®, Folex®, Rheumatrex®, Amethopterin, MTX)
Mexate®, Folex®, Rheumatrex®, Amethopterin, MTX
Mitomycin (Mutamycin®, Mitomycin-C)
Morphine Sulfate (Given by IV)
Morphine Sulfate (MS Contin®, Avinza®, Kadian®, Oramorph SR®)
MS Contin®, Avinza®, Kadian®, Oramorph SR®
Mutamycin®, Mitomycin-C, given into the bladder
Nitrogen mustard (mechlorethamine, mustine, Mustargen®)
Bendamustine Hydrochloride (Treanda®)
Bexarotene (Targretin®), Oral Formulation
Bexarotene Gel (Targretin® Gel Formulation)
Etoposide (Toposar®, VePesid®, Etopophos®,VP-16)
Thioguanine (6-TG, Thioguanine Tabloid®)
Toposar®, VePesid®, Etopophos®,VP-16
Trelstar LA® and Trelstar Depot®
Tretinoin (Vesanoid®, All-Trans-Retinoic Acid, ATRA)
Triptorelin (Trelstar LA® and Trelstar Depot®)

